SCHEMBL1114540

SCHEMBL1114540

CCCC1CC(=O)N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1114445 1.00
Hydrochloric Acid SCHEMBL1114698 0.98
Isopropylamine SCHEMBL11649882 0.89 ALDH1A1 (0.44)
SCHEMBL4461377 0.84 ALDH1A1 (0.69)
SCHEMBL28660449 0.82 ALDH1A1 (0.72)
SCHEMBL28660448 0.82 ALDH1A1 (0.72)
SCHEMBL4559467 0.81
SCHEMBL14314366 0.81
SCHEMBL5768296 0.81
Hydrochloric Acid SCHEMBL7283914 0.81 ALDH1A1 (0.70)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12460042-B2 Caprolactam-modified liquid mdi and its use in polyurethanes BASF SE (DE) 2025-11-04 US claimed
CN-118931071-A Oil seal material and preparation method thereof 青岛海力威新材料科技股份有限公司 2024-11-12 CN claimed
US-20230287166-A1 CAPROLACTAM-MODIFIED LIQUID MDI AND ITS USE IN POLYURETHANES BASF SE (DE) 2023-09-14 US claimed
EP-4192897-A1 CAPROLACTAM-MODIFIED LIQUID MDI AND ITS USE IN POLYURETHANES BASF SE (DE) 2023-06-14 EP claimed
WO-2022029289-A1 CAPROLACTAM-MODIFIED LIQUID MDI AND ITS USE IN POLYURETHANES BASF SE (DE) 2022-02-10 WO claimed
CN-102285893-A Biochemical synthesis of 6-amino caproic acid 2011-12-21 CN claimed
CN-1200724-A Process for preparing amido-carboxylic acid esters having internal amide linkages EASTMAN CHEM CO (US) 1998-12-02 CN claimed
EP-0083332-A2 Asymmetric reduction of nitro-containing prochiral compounds MONSANTO COMPANY (US) 1983-07-06 EP claimed
US-3939153-A Process for producing caprolactam HILLYARD CHEMICAL COMPANY (US) 1976-02-17 US claimed
US-12552873-B2 Anti-PSGL-1 compositions and methods for modulating myeloid cell inflammatory phenotypes and uses thereof VERSEAU THERAPEUTICS, INC. (US) 2026-02-17 US disclosed
US-12460042-B2 Caprolactam-modified liquid mdi and its use in polyurethanes BASF SE (DE) 2025-11-04 US disclosed
CN-114846064-B Method for degrading plastic products 卡比奥斯公司 2025-05-06 CN disclosed
WO-2025081024-A2 SYSTEMS, METHODS, AND COMPOSITIONS RELATED TO COPOLYMERIZATION OF CRYSTALLIZABLE POLYMERS FOR ENZYMATIC DEGRADATION Protein Evolution Inc. (US) 2025-04-17 WO disclosed
CN-118931071-A Oil seal material and preparation method thereof 青岛海力威新材料科技股份有限公司 2024-11-12 CN disclosed
EP-0281954-A1 Aromatic polyamides based on phenoxyterephthalic acid, and methods for their preparation HÜLS AKTIENGESELLSCHAFT (DE) 1988-09-14 EP disclosed
US-4600534-A Process and intermediates for manufacture of 3-(5-amino-1-carboxypentylamino)-tetrahydro-1-benzazepin-2-one-1-acetic acid CIBA-GEIGY CORPORATION (US) 1986-07-15 US disclosed
EP-0083332-A3 ASYMMETRIC REDUCTION OF NITRO-CONTAINING PROCHIRAL COMPOUNDS MONSANTO COMPANY (US) 1985-03-27 EP disclosed
EP-0083332-A2 Asymmetric reduction of nitro-containing prochiral compounds MONSANTO COMPANY (US) 1983-07-06 EP disclosed
EP-0083332-A2 Asymmetric reduction of nitro-containing prochiral compounds MONSANTO COMPANY (US) 1983-07-06 EP disclosed
EP-0022455-B1 A PROCESS FOR THE PREPARATION OF STRIKING SURFACES FOR MATCHES HOECHST AKTIENGESELLSCHAFT (DE) 1983-02-09 EP disclosed